DPHARMA

Quarterly rpt on consolidated results for the financial period ended 31/12/2008

CCM DUOPHARMA BIOTECH BERHAD

Financial Year End

31/12/2008
Quarter4
Quarterly report for the financial period ended31/12/2008
The figureshave not been audited

Attachments

Q4 2008 (Final).xls
96 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2008

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/12/2008
31/12/2007
31/12/2008
31/12/2007
RM'000
RM'000
RM'000
RM'000
1Revenue
29,484
32,068
122,872
115,551
2Profit/(loss) before tax
3,612
11,384
35,340
42,587
3Profit/(loss) for the period
3,517
9,009
27,403
32,043
4Profit/(loss) attributable to ordinary equity holders of the parent
3,517
9,009
27,403
32,043
5Basic earnings/(loss) per share (sen)
2.53
6.49
19.74
23.09
6Proposed/Declared dividend per share (sen)
7.00
0.00
15.00
48.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
0.9400
0.8200

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NameCCM DUOPHARMA BIOTECH BERHAD  
Stock Name CCMDBIO    
Date Announced24 Feb 2009  
CategoryFinancial Results
Reference NoCD-090223-35431